Tfb Advisors LLC Edwards Lifesciences Corp Transaction History

Tfb Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$81.41 - $94.33 $35,331 - $40,939	434 Added 14.16%	3,499 $330,000
Q1 2023 Apr 10, 2023	SELL	$74.26 - $84.51 $18,045 - $20,535	-243 Reduced 7.35%	3,065 $253,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $225,936 - $289,251	3,308 New	3,308 $246,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Tfb Advisors LLC with notifications on news.